Expression of Progesterone Receptor in human keratinocytes

Journal of Korean Medical Science

Volumn 15, Issue 6, 2000, Pages 647-654

  Im, Sungbin ^a   Lee, Eun So ^a   Kim, Wankee ^a   Song, Jisub ^a   Kim, Jaehyun ^a   Lee, Miok ^a   Kang, Won Hyoung ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Keratinocytes; Receptors, Estrogen; Receptors, Progesterone

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DNA SEQUENCE; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; INFANT; KERATINOCYTE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN DISEASE;

ADOLESCENT; ADULT; AGED; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; KERATINOCYTES; MALE; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SKIN; SKIN DISEASES;

EID: 0034572381     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2000.15.6.647     Document Type: Article

References (38)

1. Lawley TJ, Hertz HC, Wade TR, Ackeman AB, Katz SI. Pruritic urticarial papule and plaque of pregnancy. JAMA 1979; 241: 1696-9.
2. Boyd AS, Morris LF, Phillips CM, Menter MA. Psoriasis and pregnancy: Hormone and immune system interaction. Int J Dermatol 1996; 35: 169-72.
3. Atanes A, Gomez N, Aspe B, Toro JD, Grana J, Sanchez JM, Galdo F. Erythema nodosum: a study of 160 cases. Med Clin (Barc) 1991; 96: 169-72.
4. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698-710.
5. Hughes SV, Robinson E, Bland R, Lewis HM, Stewart PM, Hewison M. 1,25-dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes. Endocrinology 1997; 138: 3711-8.
6. Urano R, Sakabe K, Seiki K, Ohkido M. Female sex hormone stimulates cultured human keratinocyte proliferation and its RNA- and protein-synthetic activities. J Dermatol Sci 1995; 9: 176-84.
7. Arnold SF, Klotz DM, Vonier PM, Collins BM, McLachlan JA. Synergism in estrogen-regulated gene expression. Mol Cell Endocrionol 1996; 123: 119-22.
8. Gronemeyer H. Control of transcription activation by steroid hormone receptors. FASEB J 1992; 6: 2524-9.
9. Sasano, H, Nagura H, Harada N, Goukon Y, Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 1994; 25: 530-5.
10. Viale G, Doglioni C, Gambacorta M, Zamboni G, Coggi G, Bordi C. Progesterone receptor immunoreactivity in pancreatic endocrine tumor. Cancer 1992; 70: 2268-77.
11. Mason BH, Holdaway IM, Mullins PR, Wee LH, Kay RG. Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res 1983; 43: 2985-90.
12. Ingamells S, Campbell IG, Anthony FW, Thomas EJ. Endometrial progesterone receptor expression during the human menstrual cycle. J Reprod Fertil 1996; 106: 33-8.
13. Kang KS, Morita I, Cruz A, Jeon YJ, Trosko JE, Chang CC. Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines. Carcinogenesis 1997; 18: 251-7.
14. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986; 231: 1150-4.
15. Misrahi M, Atger M, d'Auriol L, Loosfelt H, Meriel C, Fridlansky F, Guiochon-Mantel A, Galibert F, Milgrom E. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun 1987; 143: 740-8.
16. Gao YL, Twiggs LB, Leung BS, Yu WC, Polish RA, Okagaki T, Adock LL, Prem KA. Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: clinical and histopathologic correlates. Am J Obstet Gynecol 1983; 146: 299-306.
17. Khalid H, Shibata S, Kishikawa M, Yasunaga A, Iseki M, Hiura T. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Cancer 1997; 80: 2133-40.
18. Stanley M, Crowcroft NS, Quigley JP, Parkinson EK. Responses of human cervical keratinocytes in vitro to tumour promoters and diethylstilbesterol. Carcinogenesis 1985; 6: 1011-5.
19. Shahrad P, Marks R. Pharmacological effect of oestrone on human epidermis. Br J Dermatol 1977; 97: 383-6.
20. Dean HJ, Winter JSD. The effect of five synthetic progestational compounds on 5 alpha-reductase activity in genital skin fibroblast monolayers. Steroids 1984; 43: 13-24.
21. Cho H, Aronica SM, Katzenellenbogen BS. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′, 5′-monophosphate, estradiol, insulin-like growth factor-1, and serum factor. Endocrinology 1994; 134: 658-64.
22. Sergei AG. Physiology of endocrine skin interrelations. J Am Acad Dermatol 1993; 28: 981-92.
23. Jemec GBE, Wojnarowska F. The distribution of P29 protein in normal human skin. Br J Dermatol 1987; 117: 217-24.
24. Hodgins MB, Spike RC, Mackie RM. An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol 1998; 105: 216-22.
25. Hasselquist MB, Goldberg N, Schroeter A, Spelsberg TC. Isolation and characterization of the estrogen receptor in human skin. J Clin Endocrinol Metab 1980; 50: 76-82.
26. Murphy FR, Stolman LP. Generalized pustular psoriasis. Arch Dermatol 1979; 115: 1215-6.
27. Guiochon-Mantel A, Delabre K, Lescop P, Milgrom E. Intracellular traffic of steroid hormone receptors. J Steroid Biochem Mol Biol 1996; 56: 3-9.
28. Khalid H. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas. Cancer 1994; 74: 679-85.
29. Wallace ML, Smoller BR. Progesterone receptor positivity supports hormonal control of syringomas. J Cutan Pathol 1995; 22: 442-5.
30. Wallace ML, Smoller BR. Differential sensitivity of estrogen/ progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin. Am J Dermatopathol 1996; 18: 241-7.
31. Kurebayashi J, Yamamoto S, Otsuki T, Sonoo H. Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect. Br J Cancer 1999; 79: 631-6.
32. Telleria CM, Ou J, Sugino N, Ferguson S, Gibori G. The expression of interleukin-6 in the pregnant rat corpus luteum and its regulation by progesterone and glucocorticoid. Endocrinology 1998; 139: 3597-605.
33. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 1991; 254: 1636-9.
34. Cho H, Katzenellenbogen BS. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kitjase activators. Mol Endocrinol 1993; 7: 441-52.
35. Denner LA, Weigel NL, Maxwell BL, Schrader WT, O'Maller BW. Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 1990; 250: 1740-3.
36. Berthois Y, Dong XF, Martin PM. Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7. Biochem Biophys Res Commun 1989; 159: 126-31.
37. Ewing TM, Murphy LJ, Ng ML, Pang GY, Lee CS, Watts CK, Sutherland RL. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines. Int J Cancer 1989; 44: 744-52.
38. Edwards DP, Altmann M, DeMarzo A, Zhang Y, Weigel NL, Beck CA. Progesterone receptor and the mechanism of action of progesterone antagonists. J Steroid Biochem Mol Biol 1995; 53: 449-58.